Internal Medicine · New York, NY
NPI
1497837090
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
53 Elizabeth St Rm 3b
New York, NY, 10013
Phone (212) 796-2828
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
1,598 services
Medicare patients, 2024
185
Average age 76
Drug cost, 2024
$4.8M
35,775 prescriptions
Company payments, 2025
$2,521
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wingtat Mui was code 99213 (office e&m - established), 476 times for 161 patients. In total Wingtat Mui billed 1,598 services in 27 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 476 | 161 | $58.46 | $28K |
| 36415 Venipuncture Blood Collection | Office | 221 | 137 | $8.65 | $1,912 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 210 | 85 | $35.46 | $7,446 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 113 | 113 | $136.86 | $15K |
| 99212 Office E&M - Established | Office | 104 | 75 | $35.65 | $3,707 |
| G0008 Administration of influenza virus vaccine | Office | 102 | 101 | $36.26 | $3,699 |
| 90661 Vaccine Product | Office | 97 | 97 | $36.11 | $3,503 |
| 93000 Electrocardiogram | Office | 87 | 80 | $9.79 | $852 |
| 99214 Office E&M - Established | Office | 61 | 56 | $84.30 | $5,142 |
| 99203 Office E&M - New | Office | 20 | 20 | $83.34 | $1,667 |
| 99497 Care Management/Coordination | Office | 14 | 14 | $60.88 | $852 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 14 | 13 | $35.58 | $498 |
By year: 2022 $103K for 2,205 services; 2023 $91K for 1,925 services; 2024 $76K for 1,598 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 221 | 137 | $8.65 | $1,912 |
Medicare prescription drug claims, 2024
In 2024, the drug Wingtat Mui prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,949 prescriptions and refills. In total Wingtat Mui wrote 35,775 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,949 | 3,428 | 393 | $13K |
| Losartan Potassium Generic | 1,541 | 2,678 | 328 | $8,877 |
| Amlodipine Besylate Generic | 1,513 | 2,602 | 298 | $7,215 |
| Vascepa Icosapent Ethyl | 1,333 | 1,864 | 256 | $641K |
| Omeprazole Generic | 899 | 1,232 | 237 | $9,139 |
| Simvastatin Generic | 854 | 1,353 | 157 | $3,981 |
| Metoprolol Succinate Generic | 796 | 1,345 | 164 | $7,003 |
| Diclofenac Epolamine Generic | 763 | 997 | 169 | $673K |
| Metformin Hcl Generic | 734 | 1,252 | 141 | $3,781 |
| Donepezil Hcl Generic | 725 | 965 | 133 | $4,002 |
| Tamsulosin Hcl Generic | 705 | 1,079 | 154 | $5,207 |
| Raloxifene Hcl Generic | 659 | 947 | 119 | $11K |
| Rosuvastatin Calcium Generic | 508 | 890 | 107 | $3,435 |
| Olmesartan Medoxomil Generic | 479 | 839 | 96 | $3,727 |
| Gabapentin Generic | 454 | 517 | 113 | $3,823 |
Brand drugs: 6,897 claims; generic drugs: 28,192 claims; opioid claims: 85.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wingtat Mui $2,521 ($2,521 in general payments such as food, travel and fees) from 13 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $564.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 26 | $564 |
| Gilead Sciences, Inc. GILD | 19 | $556 |
| GlaxoSmithKline, LLC. GSK | 25 | $442 |
| Novo Nordisk Inc NVO | 10 | $225 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $186 |
| Esperion Therapeutics, Inc. ESPR | 9 | $176 |
| Amgen Inc. AMGN | 4 | $93.04 |
| Kowa Pharmaceuticals America, Inc. | 5 | $86.63 |
| Abbvie Inc. ABBV | 3 | $62.64 |
| ViiV Healthcare Company GSK | 2 | $50.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.